Ebola - A growing threat?

New England Journal of Medicine

Volumn 371, Issue 15, 2014, Pages 1375-1378

  Feldmann, Heinz ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MORPHOLINO OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

AFRICA; BACTERIAL VIRULENCE; BLEEDING; DIARRHEA; DISEASE COURSE; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; FEVER; HUMAN; NONHUMAN; PATHOGENICITY; PATIENT SAFETY; PLASMID; PUBLIC HEALTH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VOMITING; ANIMAL; ARTICLE; DISEASE CARRIER; ULTRASTRUCTURE; ZOONOSIS;

AFRICA; ANIMALS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; ZOONOSES;

EID: 84907396242     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1405314     Document Type: Article

References (5)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea - preliminary report. N Engl J Med. DOI: 10.1056/NEJMoa1404505.
2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377:849-62.
3. Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009;5(7):e1000536.
4. Friedrich BM, Trefry JC, Biggins JE, et al. Potential vaccines and post-exposure treatments for filovirus infections. Viruses 2012; 4:1619-50.
5. Falzarano D, Feldmann H. Possible leap ahead in filovirus therapeutics. Cell Res 2014 April 15 (Epub ahead of print).